Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Immunocore Holdings (IMCR) Other Non Operating Income (2023 - 2025)

Immunocore Holdings (IMCR) has disclosed Other Non Operating Income for 3 consecutive years, with $4.5 million as the latest value for Q4 2025.

  • Quarterly Other Non Operating Income rose 353.58% to $4.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $14.3 million through Dec 2025, up 600.15% year-over-year, with the annual reading at $19.7 million for FY2025, 38.95% up from the prior year.
  • Other Non Operating Income hit $4.5 million in Q4 2025 for Immunocore Holdings, down from $5.1 million in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $11.2 million in Q3 2023 to a low of -$12.5 million in Q4 2023.
  • Historically, Other Non Operating Income has averaged $737750.0 across 3 years, with a median of $401500.0 in 2023.
  • Biggest five-year swings in Other Non Operating Income: crashed 167.37% in 2024 and later soared 353.58% in 2025.
  • Year by year, Other Non Operating Income stood at -$12.5 million in 2023, then surged by 107.93% to $993000.0 in 2024, then skyrocketed by 353.58% to $4.5 million in 2025.
  • Business Quant data shows Other Non Operating Income for IMCR at $4.5 million in Q4 2025, $5.1 million in Q3 2025, and -$738000.0 in Q2 2025.